ZNF385A antibody (C-Term)

Catalog No. ABIN1109583

Product Details anti-ZNF385A Antibody

Target: ZNF385A (Zinc Finger Protein 385A (ZNF385A))

Binding Specificity: C-Term

Reactivity: Human, Mouse, Rat, Cow, Zebrafish (Danio rerio)

Host: Rabbit

Clonality: Polyclonal

Conjugate: This ZNF385A antibody is un-conjugated

Application: Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Sequence: LKQHISSRRH RDGVAGKPNP LLSRHKKSRG AGELAGTLTF SKELPKSLAG

Cross-Reactivity (Details): Species reactivity (expected):Mouse, Rat, Zebrafish, BovineSpecies reactivity (tested):Human

Purification: Purified on peptide immunoaffinity column

Immunogen: The immunogen for anti-ZNF385 antibody: synthetic peptide directed towards the C terminal of human ZNF385.

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Handling

Reconstitution: Add 50 μL of distilled water

Handling Advice: Avoid repeated freezing and thawing.

Storage: -20 °C

Storage Comment: Store the lyophised antibody at -20 °C for up to one year. Store reconstitued antibody undiluted for one month or in aliquots at -20 °C long term.

Expiry Date: 12 months

Target Details for ZNF385A

Target: ZNF385A (Zinc Finger Protein 385A (ZNF385A))

Alternative Name: ZNF385A (ZNF385A Products)

Synonyms: HZF antibody, RZF antibody, ZFP385 antibody, ZNF385 antibody, Hzf antibody, Zfp385 antibody, Znf385a antibody, si:dkey-228g21.6 antibody, wu:fj44b04 antibody, zinc finger protein 385A antibody, ZNF385A antibody, Zfp385a antibody, znf385a antibody

Background: Results suggest that RZF is a shuttling regulatory protein expressed in photoreceptors of the human retina that may be involved in mRNA or protein regulation of photoreceptor-specific genes and therefore have role in retinal disease mechanisms.Synonyms: HZF, Hematopoietic zinc finger protein, RZF, Retinal zinc finger protein, ZNF385, Zinc finger protein 385A

Gene ID: 25946

NCBI Accession: NP_056296

Pathways: Positive Regulation of Response to DNA Damage Stimulus, Negative Regulation of intrinsic apoptotic Signaling, Positive Regulation of fat Cell Differentiation